諫田 淳也

最終更新日時: 2019/06/14 22:49:52

印刷する

氏名(漢字/フリガナ/アルファベット表記)
諫田 淳也/カンダ ジユンヤ/Kanda, Junya
所属部署・職名(部局/所属/講座等/職名)
医学部附属病院/血液内科/助教
取得学位
学位名(日本語) 学位名(英語) 大学(日本語) 大学(英語) 取得区分
博士(医学) Ph. D (medical) 京都大学 Kyoto University
ORCID ID
https://orcid.org/0000-0002-6704-3633
researchmap URL
https://researchmap.jp/yjk
研究テーマ
(日本語)
同種造血幹細胞移植における予後予測因子の検討と新規治療法の開発
(英語)
Searching for prognostic factors and developing new therapyin allogeneic hematopoietic stem cell transplantation
研究概要
(日本語)
同種造血細胞移植は、再発難治性造血器疾患に対する根治的治療である。患者データや検体を用いて予後予測因子の検討を行い、その結果に基づいた新規治療法の開発を試みている。
(英語)
Allogeneic hematopoietic stem cell transplantation is a curative treatment for relapsed and refractory hematologic diseases. We are searching for new prognostic factors using patient data and samples, and developing new treatment based on their results.
研究分野(キーワード)
キーワード(日本語) キーワード(英語)
同種造血幹細胞移植 Allogeneic hematopoietic stem cell transplantation
臍帯血移植 Cord blood transplantation
HLA HLA
臨床試験 Clinical trial
後方視的研究 Retrospective analysis
論文
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Guest Editorial: Are “alternative” stem cell sources still alternative in the new era? Guest Editorial: Are “alternative” stem cell sources still alternative in the new era? Guest Editorial: Are “alternative” stem cell sources still alternative in the new era? International Journal of Hematology International Journal of Hematology International Journal of Hematology 2019/05 公開
Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis Leukemia Leukemia Leukemia 2019/05 公開
Yanada M, Konuma T, Kuwatsuka Y, Kondo T, Kawata T, Takahashi S, Uchida N, Miyakoshi S, Tanaka M, Ozawa Y, Sawa M, Nakamae H, Aotsuka N, Kanda J, Yano S Yanada M, Konuma T, Kuwatsuka Y, Kondo T, Kawata T, Takahashi S, Uchida N, Miyakoshi S, Tanaka M, Ozawa Y, Sawa M, Nakamae H, Aotsuka N, Kanda J, Yano S Yanada M, Konuma T, Kuwatsuka Y, Kondo T, Kawata T, Takahashi S, Uchida N, Miyakoshi S, Tanaka M, Ozawa Y, Sawa M, Nakamae H, Aotsuka N, Kanda J, Yano S Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience. Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience. Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience. Bone marrow transplantation Bone marrow transplantation Bone marrow transplantation 2019/05 公開
Mizuki Watanabe, Junya Kanda, Masakatsu Hishizawa, Tadakazu Kondo, Kouhei Yamashita, Akifumi Takaori-Kondo Mizuki Watanabe, Junya Kanda, Masakatsu Hishizawa, Tadakazu Kondo, Kouhei Yamashita, Akifumi Takaori-Kondo Mizuki Watanabe, Junya Kanda, Masakatsu Hishizawa, Tadakazu Kondo, Kouhei Yamashita, Akifumi Takaori-Kondo Impact of cumulative steroid dose on infectious diseases after allogenic hematopoietic stem cell transplantation Impact of cumulative steroid dose on infectious diseases after allogenic hematopoietic stem cell transplantation Impact of cumulative steroid dose on infectious diseases after allogenic hematopoietic stem cell transplantation Transplant Infectious Disease, 21, 2, e13049 Transplant Infectious Disease, 21, 2, e13049 Transplant Infectious Disease, 21, 2, e13049 2019/04 公開
Shimomura Y, Hara M, Tachibana T, Ohashi K, Sakura T, Fukuda T, Nakazawa H, Iwato K, Kanda Y, Ikeda T, Eto T, Kanda J, Ichinohe T, Atsuta Y, Ishikawa T, Ishiyama K Shimomura Y, Hara M, Tachibana T, Ohashi K, Sakura T, Fukuda T, Nakazawa H, Iwato K, Kanda Y, Ikeda T, Eto T, Kanda J, Ichinohe T, Atsuta Y, Ishikawa T, Ishiyama K Shimomura Y, Hara M, Tachibana T, Ohashi K, Sakura T, Fukuda T, Nakazawa H, Iwato K, Kanda Y, Ikeda T, Eto T, Kanda J, Ichinohe T, Atsuta Y, Ishikawa T, Ishiyama K Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome. Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome. Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome. British journal of haematology British journal of haematology British journal of haematology 2019/04 公開
ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation Bone Marrow Transplantation Bone Marrow Transplantation Bone Marrow Transplantation 2019/03 公開
Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, Mori T, Sawa M, Ichinohe T, Atsuta Y, Kanda J, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, Mori T, Sawa M, Ichinohe T, Atsuta Y, Kanda J, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, Mori T, Sawa M, Ichinohe T, Atsuta Y, Kanda J, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT. Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT. Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT. International journal of hematology International journal of hematology International journal of hematology 2019/03 公開
Sawayama Y, Itonaga H, Fukushima T, Nakano N, Fujiwara H, Utsunomiya A, Fukuda T, Miyamoto T, Eto T, Miyashita K, Nakamae H, Ogata M, Yamanoha A, ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation Sawayama Y, Itonaga H, Fukushima T, Nakano N, Fujiwara H, Utsunomiya A, Fukuda T, Miyamoto T, Eto T, Miyashita K, Nakamae H, Ogata M, Yamanoha A, ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation Sawayama Y, Itonaga H, Fukushima T, Nakano N, Fujiwara H, Utsunomiya A, Fukuda T, Miyamoto T, Eto T, Miyashita K, Nakamae H, Ogata M, Yamanoha A, ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma. Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma. Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma. American journal of hematology American journal of hematology American journal of hematology 2019/03 公開
Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation Bone Marrow Transplantation Bone Marrow Transplantation Bone Marrow Transplantation 2019/01 公開
Kazuhiko Ikeda, Hitoshi Ohto, Yoshiki Okuyama, Minami Yamada-Fujiwara, Heiwa Kanamori, Shin-ichiro Fujiwara, Kazuo Muroi, Takehiko Mori, Kinuyo Kasama, Tohru Iseki, Tokiko Nagamura-Inoue, Nobuharu Fujii, Takashi Ashida, Kazuaki Kameda, Junya Kanda, Asao Hirose, Tsutomu Takahashi, Kazuhiro Nagai, Keiji Minakawa, Ryuji Tanosaki Kazuhiko Ikeda, Hitoshi Ohto, Yoshiki Okuyama, Minami Yamada-Fujiwara, Heiwa Kanamori, Shin-ichiro Fujiwara, Kazuo Muroi, Takehiko Mori, Kinuyo Kasama, Tohru Iseki, Tokiko Nagamura-Inoue, Nobuharu Fujii, Takashi Ashida, Kazuaki Kameda, Junya Kanda, Asao Hirose, Tsutomu Takahashi, Kazuhiro Nagai, Keiji Minakawa, Ryuji Tanosaki Kazuhiko Ikeda, Hitoshi Ohto, Yoshiki Okuyama, Minami Yamada-Fujiwara, Heiwa Kanamori, Shin-ichiro Fujiwara, Kazuo Muroi, Takehiko Mori, Kinuyo Kasama, Tohru Iseki, Tokiko Nagamura-Inoue, Nobuharu Fujii, Takashi Ashida, Kazuaki Kameda, Junya Kanda, Asao Hirose, Tsutomu Takahashi, Kazuhiro Nagai, Keiji Minakawa, Ryuji Tanosaki Adverse Events Associated with Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study Adverse Events Associated with Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study Adverse Events Associated with Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study Transfusion Medicine Reviews Transfusion Medicine Reviews Transfusion Medicine Reviews 2018/06 公開
Wada H, Kanda J, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kanda Y Wada H, Kanda J, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kanda Y Wada H, Kanda J, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kanda Y Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation. Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation. Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation. Hematology (Amsterdam, Netherlands) Hematology (Amsterdam, Netherlands) Hematology (Amsterdam, Netherlands) 2018/06 公開
Motohiro Kato, Mio Kurata, Junya Kanda, Koji Kato, Daisuke Tomizawa, Kazuko Kudo, Nao Yoshida, Kenichiro Watanabe, Hiroyuki Shimada, Jiro Inagaki, Katsuyoshi Koh, Hiroaki Goto, Keisuke Kato, Yuko Cho, Yuki Yuza, Atsushi Ogawa, Keiko Okada, Masami Inoue, Yoshiko Hashii, Takanori Teshima, Makoto Murata, Yoshiko Atsuta Motohiro Kato, Mio Kurata, Junya Kanda, Koji Kato, Daisuke Tomizawa, Kazuko Kudo, Nao Yoshida, Kenichiro Watanabe, Hiroyuki Shimada, Jiro Inagaki, Katsuyoshi Koh, Hiroaki Goto, Keisuke Kato, Yuko Cho, Yuki Yuza, Atsushi Ogawa, Keiko Okada, Masami Inoue, Yoshiko Hashii, Takanori Teshima, Makoto Murata, Yoshiko Atsuta Motohiro Kato, Mio Kurata, Junya Kanda, Koji Kato, Daisuke Tomizawa, Kazuko Kudo, Nao Yoshida, Kenichiro Watanabe, Hiroyuki Shimada, Jiro Inagaki, Katsuyoshi Koh, Hiroaki Goto, Keisuke Kato, Yuko Cho, Yuki Yuza, Atsushi Ogawa, Keiko Okada, Masami Inoue, Yoshiko Hashii, Takanori Teshima, Makoto Murata, Yoshiko Atsuta Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia Bone Marrow Transplantation, 54, 1, 68 Bone Marrow Transplantation, 54, 1, 68 Bone Marrow Transplantation, 54, 1, 68 2018/05 公開
Konuma T, Yanada M, Yamasaki S, Kuwatsuka Y, Fukuda T, Kobayashi T, Ozawa Y, Uchida N, Ota S, Hoshino T, Takahashi S, Kanda Y, Ueda Y, Takanashi M, Yano S Konuma T, Yanada M, Yamasaki S, Kuwatsuka Y, Fukuda T, Kobayashi T, Ozawa Y, Uchida N, Ota S, Hoshino T, Takahashi S, Kanda Y, Ueda Y, Takanashi M, Yano S Konuma T, Yanada M, Yamasaki S, Kuwatsuka Y, Fukuda T, Kobayashi T, Ozawa Y, Uchida N, Ota S, Hoshino T, Takahashi S, Kanda Y, Ueda Y, Takanashi M, Yano S Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT). Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT). Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT). British journal of haematology British journal of haematology British journal of haematology 2018/05 公開
Tachibana T, Kanda J, Machida S, Saito T, Tanaka M, Najima Y, Koyama S, Miyazaki T, Yamamoto E, Takeuchi M, Morita S, Kanda Y, Kanamori H, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT) Tachibana T, Kanda J, Machida S, Saito T, Tanaka M, Najima Y, Koyama S, Miyazaki T, Yamamoto E, Takeuchi M, Morita S, Kanda Y, Kanamori H, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT) Tachibana T, Kanda J, Machida S, Saito T, Tanaka M, Najima Y, Koyama S, Miyazaki T, Yamamoto E, Takeuchi M, Morita S, Kanda Y, Kanamori H, Okamoto S, Kanto Study Group for Cell Therapy (KSGCT) Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302). Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302). Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302). International journal of hematology International journal of hematology International journal of hematology 2018/05 公開
Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, Kanda Y Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, Kanda Y Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, Kanda Y Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia. Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia. Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018/04 公開
Yoshinaga N, Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Takaori-Kondo A Yoshinaga N, Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Takaori-Kondo A Yoshinaga N, Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Takaori-Kondo A Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018/03 公開
Nakasone H, Terasako-Saito K, Hirano T, Wake A, Shimizu S, Kurita N, Yamazaki E, Usuki K, Akazawa K, Kanda J, Minauchi K, Yamamoto G, Tanimoto S, Kanda Y Nakasone H, Terasako-Saito K, Hirano T, Wake A, Shimizu S, Kurita N, Yamazaki E, Usuki K, Akazawa K, Kanda J, Minauchi K, Yamamoto G, Tanimoto S, Kanda Y Nakasone H, Terasako-Saito K, Hirano T, Wake A, Shimizu S, Kurita N, Yamazaki E, Usuki K, Akazawa K, Kanda J, Minauchi K, Yamamoto G, Tanimoto S, Kanda Y Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Hematological oncology Hematological oncology Hematological oncology 2018/02 公開
Kameda K, Kako S, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Kanda J, Tanihara A, Wada H, Kanda Y Kameda K, Kako S, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Kanda J, Tanihara A, Wada H, Kanda Y Kameda K, Kako S, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Kanda J, Tanihara A, Wada H, Kanda Y Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin. Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin. Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin. Annals of hematology Annals of hematology Annals of hematology 2018/01 公開
Kameda K, Nakasone H, Komiya Y, Kanda J, Gomyo A, Hayakawa J, Akahoshi Y, Tamaki M, Harada N, Kusuda M, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Kanda Y Kameda K, Nakasone H, Komiya Y, Kanda J, Gomyo A, Hayakawa J, Akahoshi Y, Tamaki M, Harada N, Kusuda M, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Kanda Y Kameda K, Nakasone H, Komiya Y, Kanda J, Gomyo A, Hayakawa J, Akahoshi Y, Tamaki M, Harada N, Kusuda M, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Kanda Y Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors. Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors. Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017/11 公開
Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation Bone Marrow Transplantation Bone Marrow Transplantation Bone Marrow Transplantation 2017/10 公開
Yui S, Kurosawa S, Yamaguchi H, Kanamori H, Ueki T, Uoshima N, Mizuno I, Shono K, Usuki K, Chiba S, Nakamura Y, Yanada M, Kanda J, Tajika K, Gomi S, Inokuchi K Yui S, Kurosawa S, Yamaguchi H, Kanamori H, Ueki T, Uoshima N, Mizuno I, Shono K, Usuki K, Chiba S, Nakamura Y, Yanada M, Kanda J, Tajika K, Gomi S, Inokuchi K Yui S, Kurosawa S, Yamaguchi H, Kanamori H, Ueki T, Uoshima N, Mizuno I, Shono K, Usuki K, Chiba S, Nakamura Y, Yanada M, Kanda J, Tajika K, Gomi S, Inokuchi K D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations. D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations. D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations. Annals of hematology Annals of hematology Annals of hematology 2017/10 公開
S Terakura, Y Kuwatsuka, S Yamasaki, A Wake, J Kanda, Y Inamoto, S Mizuta, T Yamaguchi, N Uchida, Y Kouzai, N Aotsuka, H Ogawa, H Kanamori, K Nishiwaki, S Miyakoshi, M Onizuka, I Amano, T Fukuda, T Ichinohe, Y Atsuta, M Murata, T Teshima S Terakura, Y Kuwatsuka, S Yamasaki, A Wake, J Kanda, Y Inamoto, S Mizuta, T Yamaguchi, N Uchida, Y Kouzai, N Aotsuka, H Ogawa, H Kanamori, K Nishiwaki, S Miyakoshi, M Onizuka, I Amano, T Fukuda, T Ichinohe, Y Atsuta, M Murata, T Teshima S Terakura, Y Kuwatsuka, S Yamasaki, A Wake, J Kanda, Y Inamoto, S Mizuta, T Yamaguchi, N Uchida, Y Kouzai, N Aotsuka, H Ogawa, H Kanamori, K Nishiwaki, S Miyakoshi, M Onizuka, I Amano, T Fukuda, T Ichinohe, Y Atsuta, M Murata, T Teshima GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia Bone Marrow Transplantation Bone Marrow Transplantation Bone Marrow Transplantation 2017/09 公開
Akahoshi Y, Kanda J, Ohno A, Komiya Y, Gomyo A, Hayakawa J, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Shiraki K, Kanda Y Akahoshi Y, Kanda J, Ohno A, Komiya Y, Gomyo A, Hayakawa J, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Shiraki K, Kanda Y Akahoshi Y, Kanda J, Ohno A, Komiya Y, Gomyo A, Hayakawa J, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Shiraki K, Kanda Y Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion. Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion. Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 23, 7, 485-487 Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 23, 7, 485-487 Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 23, 7, 485-487 2017/07 公開
Yamasaki R, Kanda J, Akahoshi Y, Nakano H, Ugai T, Wada H, Kawamura K, Ishihara Y, Sakamoto K, Sato M, Ashizawa M, Machishima T, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Kanda Y Yamasaki R, Kanda J, Akahoshi Y, Nakano H, Ugai T, Wada H, Kawamura K, Ishihara Y, Sakamoto K, Sato M, Ashizawa M, Machishima T, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Kanda Y Yamasaki R, Kanda J, Akahoshi Y, Nakano H, Ugai T, Wada H, Kawamura K, Ishihara Y, Sakamoto K, Sato M, Ashizawa M, Machishima T, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Kanda Y Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia. Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia. Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia. International journal of hematology, 105, 6, 835-840 International journal of hematology, 105, 6, 835-840 International journal of hematology, 105, 6, 835-840 2017/06 公開
Hayakawa J, Kanda J, Akahoshi Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Yamazaki R, Kako S, Kanda Y Hayakawa J, Kanda J, Akahoshi Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Yamazaki R, Kako S, Kanda Y Hayakawa J, Kanda J, Akahoshi Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Yamazaki R, Kako S, Kanda Y Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia. International journal of hematology, 105, 5, 578-586 International journal of hematology, 105, 5, 578-586 International journal of hematology, 105, 5, 578-586 2017/05 公開
Kako S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kanda Y Kako S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kanda Y Kako S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kanda Y HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin). HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin). HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin). Hematology (Amsterdam, Netherlands), 22, 3, 129-135 Hematology (Amsterdam, Netherlands), 22, 3, 129-135 Hematology (Amsterdam, Netherlands), 22, 3, 129-135 2017/04 公開
Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M, Leukemia, vol. 31, no. 3, pp. 663-668 Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M, Leukemia, vol. 31, no. 3, pp. 663-668 Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M, Leukemia, vol. 31, no. 3, pp. 663-668 Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation. Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation. Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation. , 31, 3, 663-668 , 31, 3, 663-668 , 31, 3, 663-668 2017/03 公開
Kimura SI, Gomyo A, Hayakawa J, Akahoshi Y, Harada N, Ugai T, Komiya Y, Kameda K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kanda J, Kako S, Tanihara A, Kanda Y Kimura SI, Gomyo A, Hayakawa J, Akahoshi Y, Harada N, Ugai T, Komiya Y, Kameda K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kanda J, Kako S, Tanihara A, Kanda Y Kimura SI, Gomyo A, Hayakawa J, Akahoshi Y, Harada N, Ugai T, Komiya Y, Kameda K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kanda J, Kako S, Tanihara A, Kanda Y Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients. Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients. Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 23, 3, 148-153 Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 23, 3, 148-153 Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 23, 3, 148-153 2017/03 公開
Yokoyama H, Kanda J, Fuji S, Kim SW, Fukuda T, Najima Y, Ohno H, Uchida N, Ueda Y, Eto T, Iwato K, Kobayashi H, Ozawa Y, Kondo T, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Yokoyama H, Kanda J, Fuji S, Kim SW, Fukuda T, Najima Y, Ohno H, Uchida N, Ueda Y, Eto T, Iwato K, Kobayashi H, Ozawa Y, Kondo T, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Yokoyama H, Kanda J, Fuji S, Kim SW, Fukuda T, Najima Y, Ohno H, Uchida N, Ueda Y, Eto T, Iwato K, Kobayashi H, Ozawa Y, Kondo T, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 23, 2, 300-309 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 23, 2, 300-309 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 23, 2, 300-309 2017/02 公開
Yamasaki S, Hirakawa A, Aoki J, Uchida N, Fukuda T, Ogawa H, Ohashi K, Kondo T, Eto T, Kanamori H, Okumura H, Iwato K, Ichinohe T, Kanda J, Onizuka M, Kuwatsuka Y, Yanada M, Atsuta Y, Takami A, Yano S Yamasaki S, Hirakawa A, Aoki J, Uchida N, Fukuda T, Ogawa H, Ohashi K, Kondo T, Eto T, Kanamori H, Okumura H, Iwato K, Ichinohe T, Kanda J, Onizuka M, Kuwatsuka Y, Yanada M, Atsuta Y, Takami A, Yano S Yamasaki S, Hirakawa A, Aoki J, Uchida N, Fukuda T, Ogawa H, Ohashi K, Kondo T, Eto T, Kanamori H, Okumura H, Iwato K, Ichinohe T, Kanda J, Onizuka M, Kuwatsuka Y, Yanada M, Atsuta Y, Takami A, Yano S Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia. Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia. Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia. Annals of hematology, 96, 2, 289-297 Annals of hematology, 96, 2, 289-297 Annals of hematology, 96, 2, 289-297 2017/02 公開
Mori T, Kanda Y, Takenaka K, Okamoto S, Kato J, Kanda J, Yoshimoto G, Gondo H, Doi S, Inaba M, Kodera Y Mori T, Kanda Y, Takenaka K, Okamoto S, Kato J, Kanda J, Yoshimoto G, Gondo H, Doi S, Inaba M, Kodera Y Mori T, Kanda Y, Takenaka K, Okamoto S, Kato J, Kanda J, Yoshimoto G, Gondo H, Doi S, Inaba M, Kodera Y Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial. Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial. Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial. International journal of hematology, 105, 2, 212-212 International journal of hematology, 105, 2, 212-212 International journal of hematology, 105, 2, 212-212 2017/02 公開
Sakamoto S, Kawabata H, Kanda J, Uchiyama T, Mizumoto C, Kitano T, Kondo T, Hishizawa M, Tomosugi N, Takaori-Kondo A Sakamoto S, Kawabata H, Kanda J, Uchiyama T, Mizumoto C, Kitano T, Kondo T, Hishizawa M, Tomosugi N, Takaori-Kondo A Sakamoto S, Kawabata H, Kanda J, Uchiyama T, Mizumoto C, Kitano T, Kondo T, Hishizawa M, Tomosugi N, Takaori-Kondo A High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation. High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation. High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation. Cancer medicine, 6, 1, 120-128 Cancer medicine, 6, 1, 120-128 Cancer medicine, 6, 1, 120-128 2017/01 公開
Kanda J Kanda J Kanda J [Impact of HLA mismatch on transplant outcomes]. [Impact of HLA mismatch on transplant outcomes]. [Impact of HLA mismatch on transplant outcomes]. [Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho ketsueki] The Japanese journal of clinical hematology 2017 公開
Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, Inoue M, Teshima T, JSHCT GVHD Working Group. Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, Inoue M, Teshima T, JSHCT GVHD Working Group. Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, Inoue M, Teshima T, JSHCT GVHD Working Group. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups. Haematologica, 101, 12, 1592-1602 Haematologica, 101, 12, 1592-1602 Haematologica, 101, 12, 1592-1602 2016/12 公開
Kanda J, Ikegame K, Fuji S, Kurokawa M, Kanamori H, Fukuda T, Ohashi K, Ishikawa J, Ogawa H, Inoue M, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Kanda J, Ikegame K, Fuji S, Kurokawa M, Kanamori H, Fukuda T, Ohashi K, Ishikawa J, Ogawa H, Inoue M, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Kanda J, Ikegame K, Fuji S, Kurokawa M, Kanamori H, Fukuda T, Ohashi K, Ishikawa J, Ogawa H, Inoue M, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes. Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes. Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 11, 2031-2037 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 11, 2031-2037 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 11, 2031-2037 2016/11 公開
Kuwatsuka Y, Kanda J, Yamazaki H, Mori T, Miyamura K, Kako S, Uchida N, Ohashi K, Ozawa Y, Takahashi Y, Kato C, Iwato K, Ishiyama K, Kobayashi H, Eto T, Kahata K, Kato J, Miyamoto T, Kato K, Mori S, Atsuta Y, Kimura F, Kanda Y, Japan Society for Hematopoietic Cell Transplantation. Kuwatsuka Y, Kanda J, Yamazaki H, Mori T, Miyamura K, Kako S, Uchida N, Ohashi K, Ozawa Y, Takahashi Y, Kato C, Iwato K, Ishiyama K, Kobayashi H, Eto T, Kahata K, Kato J, Miyamoto T, Kato K, Mori S, Atsuta Y, Kimura F, Kanda Y, Japan Society for Hematopoietic Cell Transplantation. Kuwatsuka Y, Kanda J, Yamazaki H, Mori T, Miyamura K, Kako S, Uchida N, Ohashi K, Ozawa Y, Takahashi Y, Kato C, Iwato K, Ishiyama K, Kobayashi H, Eto T, Kahata K, Kato J, Miyamoto T, Kato K, Mori S, Atsuta Y, Kimura F, Kanda Y, Japan Society for Hematopoietic Cell Transplantation. A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia. A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia. A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 10, 1836-1843 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 10, 1836-1843 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 10, 1836-1843 2016/10 公開
Kanda J, Ikegame K, Fuji S, Kurokawa M, Kanamori H, Fukuda T, Ohashi K, Ishikawa J, Ogawa H, Inoue M, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation, Biology of blood, marrow transplantation : journal of the American Society for Blood, Marrow Transplantation Kanda J, Ikegame K, Fuji S, Kurokawa M, Kanamori H, Fukuda T, Ohashi K, Ishikawa J, Ogawa H, Inoue M, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation, Biology of blood, marrow transplantation : journal of the American Society for Blood, Marrow Transplantation Kanda J, Ikegame K, Fuji S, Kurokawa M, Kanamori H, Fukuda T, Ohashi K, Ishikawa J, Ogawa H, Inoue M, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation, Biology of blood, marrow transplantation : journal of the American Society for Blood, Marrow Transplantation Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes. Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes. Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes. 2016/08 公開
Nakano H, Ashizawa M, Akahoshi Y, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Nakano H, Ashizawa M, Akahoshi Y, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Nakano H, Ashizawa M, Akahoshi Y, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding. Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding. Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding. International journal of hematology, 104, 1, 110-116 International journal of hematology, 104, 1, 110-116 International journal of hematology, 104, 1, 110-116 2016/07 公開
Akahoshi Y, Kanda J, Gomyo A, Hayakawa J, Komiya Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Kanda Y Akahoshi Y, Kanda J, Gomyo A, Hayakawa J, Komiya Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Kanda Y Akahoshi Y, Kanda J, Gomyo A, Hayakawa J, Komiya Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Kanda Y Risk Factors and Impact of Secondary Failure of Platelet Recovery after Allogeneic Stem Cell Transplantation. Risk Factors and Impact of Secondary Failure of Platelet Recovery after Allogeneic Stem Cell Transplantation. Risk Factors and Impact of Secondary Failure of Platelet Recovery after Allogeneic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 9, 1678-1683 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 9, 1678-1683 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 9, 1678-1683 2016/06 公開
Kurosawa S, Yamaguchi H, Yamaguchi T, Fukunaga K, Yui S, Wakita S, Kanamori H, Usuki K, Uoshima N, Yanada M, Shono K, Ueki T, Mizuno I, Yano S, Takeuchi J, Kanda J, Okamura H, Inamoto Y, Inokuchi K, Fukuda T Kurosawa S, Yamaguchi H, Yamaguchi T, Fukunaga K, Yui S, Wakita S, Kanamori H, Usuki K, Uoshima N, Yanada M, Shono K, Ueki T, Mizuno I, Yano S, Takeuchi J, Kanda J, Okamura H, Inamoto Y, Inokuchi K, Fukuda T Kurosawa S, Yamaguchi H, Yamaguchi T, Fukunaga K, Yui S, Wakita S, Kanamori H, Usuki K, Uoshima N, Yanada M, Shono K, Ueki T, Mizuno I, Yano S, Takeuchi J, Kanda J, Okamura H, Inamoto Y, Inokuchi K, Fukuda T Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha. Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha. Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 6, 1125-1132 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 6, 1125-1132 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 6, 1125-1132 2016/06 公開
Akahoshi Y, Kimura S, Nakano H, Harada N, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Nishida J, Kanda Y Akahoshi Y, Kimura S, Nakano H, Harada N, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Nishida J, Kanda Y Akahoshi Y, Kimura S, Nakano H, Harada N, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Nishida J, Kanda Y Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation. Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation. Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation. Clinical transplantation, 30, 6, 703-708 Clinical transplantation, 30, 6, 703-708 Clinical transplantation, 30, 6, 703-708 2016/06 公開
Teramura Y, Kameda K, Kanda J, Gomyo A, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Wada H, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda Y Teramura Y, Kameda K, Kanda J, Gomyo A, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Wada H, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda Y Teramura Y, Kameda K, Kanda J, Gomyo A, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Wada H, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda Y Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma. Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma. Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma. [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 5, 597-601 [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 5, 597-601 [Rinsho ketsueki] The Japanese journal of clinical hematology, 57, 5, 597-601 2016/05 公開
Ryotokuji T, Yamaguchi H, Ueki T, Usuki K, Kurosawa S, Kobayashi Y, Kawata E, Tajika K, Gomi S, Kanda J, Kobayashi A, Omori I, Marumo A, Fujiwara Y, Yui S, Terada K, Fukunaga K, Hirakawa T, Arai K, Kitano T, Kosaka F, Tamai H, Nakayama K, Wakita S, Fukuda T, Inokuchi K Ryotokuji T, Yamaguchi H, Ueki T, Usuki K, Kurosawa S, Kobayashi Y, Kawata E, Tajika K, Gomi S, Kanda J, Kobayashi A, Omori I, Marumo A, Fujiwara Y, Yui S, Terada K, Fukunaga K, Hirakawa T, Arai K, Kitano T, Kosaka F, Tamai H, Nakayama K, Wakita S, Fukuda T, Inokuchi K Ryotokuji T, Yamaguchi H, Ueki T, Usuki K, Kurosawa S, Kobayashi Y, Kawata E, Tajika K, Gomi S, Kanda J, Kobayashi A, Omori I, Marumo A, Fujiwara Y, Yui S, Terada K, Fukunaga K, Hirakawa T, Arai K, Kitano T, Kosaka F, Tamai H, Nakayama K, Wakita S, Fukuda T, Inokuchi K Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations. Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations. Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations. Haematologica, 101, 9, 1074-1081 Haematologica, 101, 9, 1074-1081 Haematologica, 101, 9, 1074-1081 2016/05 公開
Konuma T, Tsukada N, Kanda J, Uchida N, Ohno Y, Miyakoshi S, Kanamori H, Hidaka M, Sakura T, Onizuka M, Kobayashi N, Sawa M, Eto T, Matsuhashi Y, Kato K, Ichinohe T, Atsuta Y, Miyamura K, Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation Konuma T, Tsukada N, Kanda J, Uchida N, Ohno Y, Miyakoshi S, Kanamori H, Hidaka M, Sakura T, Onizuka M, Kobayashi N, Sawa M, Eto T, Matsuhashi Y, Kato K, Ichinohe T, Atsuta Y, Miyamura K, Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation Konuma T, Tsukada N, Kanda J, Uchida N, Ohno Y, Miyakoshi S, Kanamori H, Hidaka M, Sakura T, Onizuka M, Kobayashi N, Sawa M, Eto T, Matsuhashi Y, Kato K, Ichinohe T, Atsuta Y, Miyamura K, Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older. American journal of hematology, 91, 5, E284-E292 American journal of hematology, 91, 5, E284-E292 American journal of hematology, 91, 5, E284-E292 2016/05 公開
Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, Kanda Y, Miyamura K, Murata M, Fukuda T, Sakamaki H, Kimura F, Seo S, Aljurf M, Yoshimi A, Milone G, Wood WA, Ustun C, Hashimi S, Pasquini M, Bonfim C, Dalal J, Hahn T, Atsuta Y, Saber W Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, Kanda Y, Miyamura K, Murata M, Fukuda T, Sakamaki H, Kimura F, Seo S, Aljurf M, Yoshimi A, Milone G, Wood WA, Ustun C, Hashimi S, Pasquini M, Bonfim C, Dalal J, Hahn T, Atsuta Y, Saber W Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, Kanda Y, Miyamura K, Murata M, Fukuda T, Sakamaki H, Kimura F, Seo S, Aljurf M, Yoshimi A, Milone G, Wood WA, Ustun C, Hashimi S, Pasquini M, Bonfim C, Dalal J, Hahn T, Atsuta Y, Saber W Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations. Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations. Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 4, 744-751 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 4, 744-751 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 4, 744-751 2016/04 公開
Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, Najima Y, Fukuda T, Uchida N, Takahashi S, Nagamura-Inoue T, Morishima Y, Miyamura K, Japan Society for Hematopoietic Cell Transplantation Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, Najima Y, Fukuda T, Uchida N, Takahashi S, Nagamura-Inoue T, Morishima Y, Miyamura K, Japan Society for Hematopoietic Cell Transplantation Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, Najima Y, Fukuda T, Uchida N, Takahashi S, Nagamura-Inoue T, Morishima Y, Miyamura K, Japan Society for Hematopoietic Cell Transplantation Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia. Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia. Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 2, 330-338 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 2, 330-338 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 2, 330-338 2016/02 公開
Kameda K, Kimura S, Akahoshi Y, Nakano H, Harada N, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kameda K, Kimura S, Akahoshi Y, Nakano H, Harada N, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kameda K, Kimura S, Akahoshi Y, Nakano H, Harada N, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation. High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation. High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 2, 371-377 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 2, 371-377 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22, 2, 371-377 2016/02 公開
Ishihara Y, Kimura S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Usuki K, Kanda Y Ishihara Y, Kimura S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Usuki K, Kanda Y Ishihara Y, Kimura S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Usuki K, Kanda Y Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma. Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma. Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma. Hematology (Amsterdam, Netherlands), 21, 1, 19-25 Hematology (Amsterdam, Netherlands), 21, 1, 19-25 Hematology (Amsterdam, Netherlands), 21, 1, 19-25 2016/01 公開
Kanda J Kanda J Kanda J Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation. Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation. Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation. International journal of hematology, 103, 1, 19-19 International journal of hematology, 103, 1, 19-19 International journal of hematology, 103, 1, 19-19 2016/01 公開
Kako S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Nishida J, Kanda Y Kako S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Nishida J, Kanda Y Kako S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Nishida J, Kanda Y Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL. Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL. Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL. Annals of hematology, 95, 1, 87-92 Annals of hematology, 95, 1, 87-92 Annals of hematology, 95, 1, 87-92 2016/01 公開
Arai Y, Kanda J, Nakasone H, Kondo T, Uchida N, Fukuda T, Ohashi K, Kaida K, Iwato K, Eto T, Kanda Y, Nakamae H, Nagamura-Inoue T, Morishima Y, Hirokawa M, Atsuta Y, Murata M, GVHD working group of the Japan Society for Hematopoietic Cell Transplantation Arai Y, Kanda J, Nakasone H, Kondo T, Uchida N, Fukuda T, Ohashi K, Kaida K, Iwato K, Eto T, Kanda Y, Nakamae H, Nagamura-Inoue T, Morishima Y, Hirokawa M, Atsuta Y, Murata M, GVHD working group of the Japan Society for Hematopoietic Cell Transplantation Arai Y, Kanda J, Nakasone H, Kondo T, Uchida N, Fukuda T, Ohashi K, Kaida K, Iwato K, Eto T, Kanda Y, Nakamae H, Nagamura-Inoue T, Morishima Y, Hirokawa M, Atsuta Y, Murata M, GVHD working group of the Japan Society for Hematopoietic Cell Transplantation Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation. Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation. Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation. Bone marrow transplantation, 51, 1, 96-102 Bone marrow transplantation, 51, 1, 96-102 Bone marrow transplantation, 51, 1, 96-102 2016/01 公開
Yanada M, Kanda J, Ohtake S, Fukuda T, Sakamaki H, Miyamura K, Miyawaki S, Uchida N, Maeda T, Nagamura-Inoue T, Asou N, Morishima Y, Atsuta Y, Miyazaki Y, Kimura F, Kobayashi Y, Takami A, Naoe T, Kanda Y Yanada M, Kanda J, Ohtake S, Fukuda T, Sakamaki H, Miyamura K, Miyawaki S, Uchida N, Maeda T, Nagamura-Inoue T, Asou N, Morishima Y, Atsuta Y, Miyazaki Y, Kimura F, Kobayashi Y, Takami A, Naoe T, Kanda Y Yanada M, Kanda J, Ohtake S, Fukuda T, Sakamaki H, Miyamura K, Miyawaki S, Uchida N, Maeda T, Nagamura-Inoue T, Asou N, Morishima Y, Atsuta Y, Miyazaki Y, Kimura F, Kobayashi Y, Takami A, Naoe T, Kanda Y Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission. Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission. Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission. European journal of haematology, 97, 3, 278-287 European journal of haematology, 97, 3, 278-287 European journal of haematology, 97, 3, 278-287 2015/12 公開
Ugai T, Hamamoto K, Kimura S, Akahoshi Y, Nakano H, Harada N, Kameda K, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Okochi T, Kanda J, Kako S, Tanaka O, Kanda Y Ugai T, Hamamoto K, Kimura S, Akahoshi Y, Nakano H, Harada N, Kameda K, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Okochi T, Kanda J, Kako S, Tanaka O, Kanda Y Ugai T, Hamamoto K, Kimura S, Akahoshi Y, Nakano H, Harada N, Kameda K, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Okochi T, Kanda J, Kako S, Tanaka O, Kanda Y A retrospective analysis of computed tomography findings in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation. A retrospective analysis of computed tomography findings in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation. A retrospective analysis of computed tomography findings in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation. European journal of radiology, 84, 12, 2663-2670 European journal of radiology, 84, 12, 2663-2670 European journal of radiology, 84, 12, 2663-2670 2015/12 公開
Kawamura K, Hayakawa J, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kawamura K, Hayakawa J, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kawamura K, Hayakawa J, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation. International journal of hematology, 102, 2, 230-237 International journal of hematology, 102, 2, 230-237 International journal of hematology, 102, 2, 230-237 2015/08 公開
Akahoshi Y, Kako S, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Nishida J, Kanda Y Akahoshi Y, Kako S, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Nishida J, Kanda Y Akahoshi Y, Kako S, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Nishida J, Kanda Y Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning. Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning. Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning. Hematology (Amsterdam, Netherlands), 20, 7, 410-415 Hematology (Amsterdam, Netherlands), 20, 7, 410-415 Hematology (Amsterdam, Netherlands), 20, 7, 410-415 2015/08 公開
Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Tsudo M, Kobayashi H, Maesako Y, Eto T, Adachi S, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Tsudo M, Kobayashi H, Maesako Y, Eto T, Adachi S, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Tsudo M, Kobayashi H, Maesako Y, Eto T, Adachi S, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch. A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch. A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch. American journal of hematology, 90, 7, 618-623 American journal of hematology, 90, 7, 618-623 American journal of hematology, 90, 7, 618-623 2015/07 公開
Kanda J Kanda J Kanda J Unrelated cord blood transplantation vs. related transplantation with HLA 1-antigen mismatch in the GVH direction. Unrelated cord blood transplantation vs. related transplantation with HLA 1-antigen mismatch in the GVH direction. Unrelated cord blood transplantation vs. related transplantation with HLA 1-antigen mismatch in the GVH direction. [Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 5, 455-463 [Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 5, 455-463 [Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 5, 455-463 2015/05 公開
Kimura S, Akahoshi Y, Nakano H, Harada N, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kimura S, Akahoshi Y, Nakano H, Harada N, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kimura S, Akahoshi Y, Nakano H, Harada N, Kameda K, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation. False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation. False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation. The Journal of infection, 70, 5, 520-540 The Journal of infection, 70, 5, 520-540 The Journal of infection, 70, 5, 520-540 2015/05 公開
Sato M, Kako S, Matsumoto K, Oshima K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Sakamoto K, Kawamura K, Ashizawa M, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Nishida J, Morita K, Kanda Y Sato M, Kako S, Matsumoto K, Oshima K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Sakamoto K, Kawamura K, Ashizawa M, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Nishida J, Morita K, Kanda Y Sato M, Kako S, Matsumoto K, Oshima K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Sakamoto K, Kawamura K, Ashizawa M, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Nishida J, Morita K, Kanda Y Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation. Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation. Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation. International journal of hematology, 101, 5, 497-504 International journal of hematology, 101, 5, 497-504 International journal of hematology, 101, 5, 497-504 2015/05 公開
Kawabata H, Uchiyama T, Sakamoto S, Kanda J, Oishi S, Fujii N, Tomosugi N, Kadowaki N, Takaori-Kondo A Kawabata H, Uchiyama T, Sakamoto S, Kanda J, Oishi S, Fujii N, Tomosugi N, Kadowaki N, Takaori-Kondo A Kawabata H, Uchiyama T, Sakamoto S, Kanda J, Oishi S, Fujii N, Tomosugi N, Kadowaki N, Takaori-Kondo A A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression. A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression. A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression. Experimental hematology, 43, 5, 404-413 Experimental hematology, 43, 5, 404-413 Experimental hematology, 43, 5, 404-413 2015/05 公開
Kimura SI, Murata T, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Kimura SI, Murata T, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Kimura SI, Murata T, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases. Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases. Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 34, 5, 951-961 European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 34, 5, 951-961 European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 34, 5, 951-961 2015/05 公開
Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M, GVHD working group of the Japan Society of Hematopoietic Cell Transplantation Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M, GVHD working group of the Japan Society of Hematopoietic Cell Transplantation Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M, GVHD working group of the Japan Society of Hematopoietic Cell Transplantation Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation. Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation. Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation. Bone marrow transplantation, 50, 4, 559-565 Bone marrow transplantation, 50, 4, 559-565 Bone marrow transplantation, 50, 4, 559-565 2015/04 公開
Kawamura K, Yamazaki R, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kawamura K, Yamazaki R, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kawamura K, Yamazaki R, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients. Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients. Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients. Hematology (Amsterdam, Netherlands), 20, 2, 77-82 Hematology (Amsterdam, Netherlands), 20, 2, 77-82 Hematology (Amsterdam, Netherlands), 20, 2, 77-82 2015/03 公開
Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kako S, Kanda J, Nishida J, Sekiguchi N, Noto S, Journal of chemotherapy, Florence, Italy), vol. 27, no. 2, pp. 99-105 Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kako S, Kanda J, Nishida J, Sekiguchi N, Noto S, Journal of chemotherapy, Florence, Italy), vol. 27, no. 2, pp. 99-105 Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kako S, Kanda J, Nishida J, Sekiguchi N, Noto S, Journal of chemotherapy, Florence, Italy), vol. 27, no. 2, pp. 99-105 Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma. Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma. Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma. , 27, 2, 99-105 , 27, 2, 99-105 , 27, 2, 99-105 2015/02 公開
Kikuchi M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kanda J, Kako S, Nishida J, Kanda Y Kikuchi M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kanda J, Kako S, Nishida J, Kanda Y Kikuchi M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kanda J, Kako S, Nishida J, Kanda Y Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 17, 1, 56-65 Transplant infectious disease : an official journal of the Transplantation Society, 17, 1, 56-65 Transplant infectious disease : an official journal of the Transplantation Society, 17, 1, 56-65 2015/02 公開
Kanda J, Ichinohe T, Fuji S, Maeda Y, Ohashi K, Fukuda T, Miyamura K, Iwato K, Eto T, Nakamae H, Kobayashi N, Mori T, Mori S, Morishima Y, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Kanda J, Ichinohe T, Fuji S, Maeda Y, Ohashi K, Fukuda T, Miyamura K, Iwato K, Eto T, Nakamae H, Kobayashi N, Mori T, Mori S, Morishima Y, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Kanda J, Ichinohe T, Fuji S, Maeda Y, Ohashi K, Fukuda T, Miyamura K, Iwato K, Eto T, Nakamae H, Kobayashi N, Mori T, Mori S, Morishima Y, Atsuta Y, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 21, 2, 305-311 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 21, 2, 305-311 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 21, 2, 305-311 2015/02 公開
Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kako S, Kanda J, Nishida J, Sekiguchi N, Noto S, Kida M, Hangaishi A, Usuki K, Kanda Y Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kako S, Kanda J, Nishida J, Sekiguchi N, Noto S, Kida M, Hangaishi A, Usuki K, Kanda Y Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kako S, Kanda J, Nishida J, Sekiguchi N, Noto S, Kida M, Hangaishi A, Usuki K, Kanda Y Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma. Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma. Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma. Journal of chemotherapy (Florence, Italy), 27, 2, 99-105 Journal of chemotherapy (Florence, Italy), 27, 2, 99-105 Journal of chemotherapy (Florence, Italy), 27, 2, 99-105 2015/02 公開
Kanda J, Mori K, Kawabata H, Kuwabara T, Mori KP, Imamaki H, Kasahara M, Yokoi H, Mizumoto C, Thoennissen NH, Koeffler HP, Barasch J, Takaori-Kondo A, Mukoyama M, Nakao K Kanda J, Mori K, Kawabata H, Kuwabara T, Mori KP, Imamaki H, Kasahara M, Yokoi H, Mizumoto C, Thoennissen NH, Koeffler HP, Barasch J, Takaori-Kondo A, Mukoyama M, Nakao K Kanda J, Mori K, Kawabata H, Kuwabara T, Mori KP, Imamaki H, Kasahara M, Yokoi H, Mizumoto C, Thoennissen NH, Koeffler HP, Barasch J, Takaori-Kondo A, Mukoyama M, Nakao K An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions. An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions. An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions. Clinical and experimental nephrology, 19, 1, 99-106 Clinical and experimental nephrology, 19, 1, 99-106 Clinical and experimental nephrology, 19, 1, 99-106 2015/02 公開
Nakane T, Fukuda T, Kanda J, Taniguchi S, Eto T, Ohashi K, Nakamae H, Kurokawa M, Mori T, Morishima Y, Nagamura-Inoue T, Sakamaki H, Atsuta Y, Murata M Nakane T, Fukuda T, Kanda J, Taniguchi S, Eto T, Ohashi K, Nakamae H, Kurokawa M, Mori T, Morishima Y, Nagamura-Inoue T, Sakamaki H, Atsuta Y, Murata M Nakane T, Fukuda T, Kanda J, Taniguchi S, Eto T, Ohashi K, Nakamae H, Kurokawa M, Mori T, Morishima Y, Nagamura-Inoue T, Sakamaki H, Atsuta Y, Murata M Age influences post-graft-versus-host disease non-relapse mortality in adults with acute graft-versus-host disease of varying severity following allogeneic hematopoietic cell transplant. Age influences post-graft-versus-host disease non-relapse mortality in adults with acute graft-versus-host disease of varying severity following allogeneic hematopoietic cell transplant. Age influences post-graft-versus-host disease non-relapse mortality in adults with acute graft-versus-host disease of varying severity following allogeneic hematopoietic cell transplant. Leukemia & lymphoma, 56, 8, 2392-2397 Leukemia & lymphoma, 56, 8, 2392-2397 Leukemia & lymphoma, 56, 8, 2392-2397 2015 公開
Kanda J, Fuji S, Kato S, Takami A, Tanaka J, Miyamura K, Ohashi K, Fukuda T, Ozawa Y, Kanamori H, Eto T, Kobayashi N, Iwato K, Morishima Y, Sakamaki H, Atsuta Y, Kanda Y, HLA Working Group, Donor/Source Working Group, Adult AML Working Group, Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation Kanda J, Fuji S, Kato S, Takami A, Tanaka J, Miyamura K, Ohashi K, Fukuda T, Ozawa Y, Kanamori H, Eto T, Kobayashi N, Iwato K, Morishima Y, Sakamaki H, Atsuta Y, Kanda Y, HLA Working Group, Donor/Source Working Group, Adult AML Working Group, Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation Kanda J, Fuji S, Kato S, Takami A, Tanaka J, Miyamura K, Ohashi K, Fukuda T, Ozawa Y, Kanamori H, Eto T, Kobayashi N, Iwato K, Morishima Y, Sakamaki H, Atsuta Y, Kanda Y, HLA Working Group, Donor/Source Working Group, Adult AML Working Group, Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation Decision analysis for donor selection in stem cell transplantation-HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor. Decision analysis for donor selection in stem cell transplantation-HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor. Decision analysis for donor selection in stem cell transplantation-HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor. Blood cancer journal, 4, 12, e263 Blood cancer journal, 4, 12, e263 Blood cancer journal, 4, 12, e263 2014/12 公開
Terasako-Saito K, Nakasone H, Tanaka Y, Yamazaki R, Sato M, Sakamoto K, Ishihara Y, Kawamura K, Akahoshi Y, Hayakawa J, Wada H, Harada N, Nakano H, Kameda K, Ugai T, Yamasaki R, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y Terasako-Saito K, Nakasone H, Tanaka Y, Yamazaki R, Sato M, Sakamoto K, Ishihara Y, Kawamura K, Akahoshi Y, Hayakawa J, Wada H, Harada N, Nakano H, Kameda K, Ugai T, Yamasaki R, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y Terasako-Saito K, Nakasone H, Tanaka Y, Yamazaki R, Sato M, Sakamoto K, Ishihara Y, Kawamura K, Akahoshi Y, Hayakawa J, Wada H, Harada N, Nakano H, Kameda K, Ugai T, Yamasaki R, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation. Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation. Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 16, 6, 930-940 Transplant infectious disease : an official journal of the Transplantation Society, 16, 6, 930-940 Transplant infectious disease : an official journal of the Transplantation Society, 16, 6, 930-940 2014/12 公開
Yamazaki R, Tanaka Y, Nakasone H, Sato M, Terasako-Saito K, Sakamoto K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Ashizawa M, Kimura SI, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Yamazaki R, Tanaka Y, Nakasone H, Sato M, Terasako-Saito K, Sakamoto K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Ashizawa M, Kimura SI, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Yamazaki R, Tanaka Y, Nakasone H, Sato M, Terasako-Saito K, Sakamoto K, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Ashizawa M, Kimura SI, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation. Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation. Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 16, 6, 904-913 Transplant infectious disease : an official journal of the Transplantation Society, 16, 6, 904-913 Transplant infectious disease : an official journal of the Transplantation Society, 16, 6, 904-913 2014/12 公開
Ishihara Y, Kanda J, Tanaka K, Nakano H, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Watanabe K, Kanda Y Ishihara Y, Kanda J, Tanaka K, Nakano H, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Watanabe K, Kanda Y Ishihara Y, Kanda J, Tanaka K, Nakano H, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Watanabe K, Kanda Y Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia. Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia. Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia. International journal of hematology, 100, 6, 607-610 International journal of hematology, 100, 6, 607-610 International journal of hematology, 100, 6, 607-610 2014/12 公開
Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Ohashi K, Kobayashi H, Maesako Y, Adachi S, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of Japan Society for Hematopoietic Cell Transplantation Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Ohashi K, Kobayashi H, Maesako Y, Adachi S, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of Japan Society for Hematopoietic Cell Transplantation Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Ohashi K, Kobayashi H, Maesako Y, Adachi S, Ichinohe T, Atsuta Y, Kanda Y, HLA Working Group of Japan Society for Hematopoietic Cell Transplantation Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT. Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT. Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT. Bone marrow transplantation, 49, 9, 1187-1192 Bone marrow transplantation, 49, 9, 1187-1192 Bone marrow transplantation, 49, 9, 1187-1192 2014/09 公開
Kimura S, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Kimura S, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Kimura S, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials. Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials. Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials. The Journal of infection, 69, 1, 13-25 The Journal of infection, 69, 1, 13-25 The Journal of infection, 69, 1, 13-25 2014/07 公開
Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M, Center for International Blood and Marrow Transplant Research (CIBMTR),and Donor/Source and GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M, Center for International Blood and Marrow Transplant Research (CIBMTR),and Donor/Source and GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M, Center for International Blood and Marrow Transplant Research (CIBMTR),and Donor/Source and GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20, 5, 662-667 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20, 5, 662-667 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20, 5, 662-667 2014/05 公開
Sato M, Nakasone H, Terasako-Saito K, Sakamoto K, Yamazaki R, Tanaka Y, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y Sato M, Nakasone H, Terasako-Saito K, Sakamoto K, Yamazaki R, Tanaka Y, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y Sato M, Nakasone H, Terasako-Saito K, Sakamoto K, Yamazaki R, Tanaka Y, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation. Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation. Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation. Bone marrow transplantation, 49, 4, 553-560 Bone marrow transplantation, 49, 4, 553-560 Bone marrow transplantation, 49, 4, 553-560 2014/04 公開
Kanda Y, Kanda J, Atsuta Y, Fuji S, Maeda Y, Ichinohe T, Takanashi M, Ohashi K, Fukuda T, Miyamura K, Mori T, Sao H, Kobayashi N, Iwato K, Sawada A, Mori S, HLA working group of the Japan Society for Hematopoietic Cell Transplantation Kanda Y, Kanda J, Atsuta Y, Fuji S, Maeda Y, Ichinohe T, Takanashi M, Ohashi K, Fukuda T, Miyamura K, Mori T, Sao H, Kobayashi N, Iwato K, Sawada A, Mori S, HLA working group of the Japan Society for Hematopoietic Cell Transplantation Kanda Y, Kanda J, Atsuta Y, Fuji S, Maeda Y, Ichinohe T, Takanashi M, Ohashi K, Fukuda T, Miyamura K, Mori T, Sao H, Kobayashi N, Iwato K, Sawada A, Mori S, HLA working group of the Japan Society for Hematopoietic Cell Transplantation Changes in the clinical impact of high-risk human leukocyte antigen allele mismatch combinations on the outcome of unrelated bone marrow transplantation. Changes in the clinical impact of high-risk human leukocyte antigen allele mismatch combinations on the outcome of unrelated bone marrow transplantation. Changes in the clinical impact of high-risk human leukocyte antigen allele mismatch combinations on the outcome of unrelated bone marrow transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20, 4, 526-535 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20, 4, 526-535 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20, 4, 526-535 2014/04 公開
Nakasone H, Terasako-Saito K, Yamazaki R, Sato M, Tanaka Y, Sakamoto K, Kurita M, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Machishima T, Ashizawa M, Kimura S, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Yamada S, Kanda Y Nakasone H, Terasako-Saito K, Yamazaki R, Sato M, Tanaka Y, Sakamoto K, Kurita M, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Machishima T, Ashizawa M, Kimura S, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Yamada S, Kanda Y Nakasone H, Terasako-Saito K, Yamazaki R, Sato M, Tanaka Y, Sakamoto K, Kurita M, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Machishima T, Ashizawa M, Kimura S, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Yamada S, Kanda Y Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts. Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts. Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts. Experimental hematology, 42, 4, 261-273 Experimental hematology, 42, 4, 261-273 Experimental hematology, 42, 4, 261-273 2014/04 公開
Ashizawa M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Ashizawa M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Ashizawa M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia. A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia. A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia. International journal of hematology, 99, 3, 311-317 International journal of hematology, 99, 3, 311-317 International journal of hematology, 99, 3, 311-317 2014/03 公開
Kimura S, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Yamasaki R, Ashizawa M, Machishima T, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Kimura S, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Yamasaki R, Ashizawa M, Machishima T, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Kimura S, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Yamasaki R, Ashizawa M, Machishima T, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine. D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine. D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine. Hematology (Amsterdam, Netherlands), 19, 2, 107-112 Hematology (Amsterdam, Netherlands), 19, 2, 107-112 Hematology (Amsterdam, Netherlands), 19, 2, 107-112 2014/03 公開
Tanaka Y, Yamazaki R, Terasako-Saito K, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Kimura S, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Tanaka Y, Yamazaki R, Terasako-Saito K, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Kimura S, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Tanaka Y, Yamazaki R, Terasako-Saito K, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Kimura S, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells. Immunology letters, 158, 1-2, 120-125 Immunology letters, 158, 1-2, 120-125 Immunology letters, 158, 1-2, 120-125 2014/03 公開
Kanda J, Long GD, Gasparetto C, Horwitz ME, Sullivan KM, Chute JP, Morris A, Shafique M, Li Z, Chao NJ, Rizzieri DA Kanda J, Long GD, Gasparetto C, Horwitz ME, Sullivan KM, Chute JP, Morris A, Shafique M, Li Z, Chao NJ, Rizzieri DA Kanda J, Long GD, Gasparetto C, Horwitz ME, Sullivan KM, Chute JP, Morris A, Shafique M, Li Z, Chao NJ, Rizzieri DA Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies. Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies. Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20, 2, 257-263 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20, 2, 257-263 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20, 2, 257-263 2014/02 公開
Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 19, 1, 26-32 International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 19, 1, 26-32 International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 19, 1, 26-32 2014/02 公開
Kanda J, Nakasone H, Atsuta Y, Toubai T, Yokoyama H, Fukuda T, Taniguchi S, Ohashi K, Ogawa H, Eto T, Miyamura K, Morishima Y, Nagamura-Inoue T, Sakamaki H, Murata M Kanda J, Nakasone H, Atsuta Y, Toubai T, Yokoyama H, Fukuda T, Taniguchi S, Ohashi K, Ogawa H, Eto T, Miyamura K, Morishima Y, Nagamura-Inoue T, Sakamaki H, Murata M Kanda J, Nakasone H, Atsuta Y, Toubai T, Yokoyama H, Fukuda T, Taniguchi S, Ohashi K, Ogawa H, Eto T, Miyamura K, Morishima Y, Nagamura-Inoue T, Sakamaki H, Murata M Risk factors and organ involvement of chronic GVHD in Japan. Risk factors and organ involvement of chronic GVHD in Japan. Risk factors and organ involvement of chronic GVHD in Japan. Bone marrow transplantation, 49, 2, 228-235 Bone marrow transplantation, 49, 2, 228-235 Bone marrow transplantation, 49, 2, 228-235 2014/02 公開
Kanda Y, Wada H, Yamasaki R, Kawamura K, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Nishida J, Tsunoda H, Omori Y, Nakazawa M, Tanaka O Kanda Y, Wada H, Yamasaki R, Kawamura K, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Nishida J, Tsunoda H, Omori Y, Nakazawa M, Tanaka O Kanda Y, Wada H, Yamasaki R, Kawamura K, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Nishida J, Tsunoda H, Omori Y, Nakazawa M, Tanaka O Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation. Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation. Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation. Annals of hematology, 93, 2, 287-292 Annals of hematology, 93, 2, 287-292 Annals of hematology, 93, 2, 287-292 2014/02 公開
Nakasone H, Tanaka Y, Yamazaki R, Terasako K, Sato M, Sakamoto K, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Machishima T, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y Nakasone H, Tanaka Y, Yamazaki R, Terasako K, Sato M, Sakamoto K, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Machishima T, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y Nakasone H, Tanaka Y, Yamazaki R, Terasako K, Sato M, Sakamoto K, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Machishima T, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT. Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT. Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT. Bone marrow transplantation, 49, 1, 87-94 Bone marrow transplantation, 49, 1, 87-94 Bone marrow transplantation, 49, 1, 87-94 2014/01 公開
Junya Kanda Junya Kanda Junya Kanda Donor selection in hematopoietic stem cell transplantation Donor selection in hematopoietic stem cell transplantation Donor selection in hematopoietic stem cell transplantation Journal of Hematopoietic Cell Transplantation, 3, 2, 39 Journal of Hematopoietic Cell Transplantation, 3, 2, 39 Journal of Hematopoietic Cell Transplantation, 3, 2, 39 2014 公開
Sung AD, Grima DT, Bernard LM, Brown S, Carrum G, Holmberg L, Horwitz ME, Liesveld JL, Kanda J, McClune B, Shaughnessy P, Tricot GJ, Chao NJ Sung AD, Grima DT, Bernard LM, Brown S, Carrum G, Holmberg L, Horwitz ME, Liesveld JL, Kanda J, McClune B, Shaughnessy P, Tricot GJ, Chao NJ Sung AD, Grima DT, Bernard LM, Brown S, Carrum G, Holmberg L, Horwitz ME, Liesveld JL, Kanda J, McClune B, Shaughnessy P, Tricot GJ, Chao NJ Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone. Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone. Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone. Bone marrow transplantation, 48, 11, 1444-1449 Bone marrow transplantation, 48, 11, 1444-1449 Bone marrow transplantation, 48, 11, 1444-1449 2013/11 公開
Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 15, 5, 457-465 Transplant infectious disease : an official journal of the Transplantation Society, 15, 5, 457-465 Transplant infectious disease : an official journal of the Transplantation Society, 15, 5, 457-465 2013/10 公開
Kawamura K, Kikuchi M, Terasako K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Kimura S, Nakasone H, Okuda S, Yamazaki R, Kanda J, Kako S, Tanaka Y, Tanihara A, Nishida J, Kanda Y Kawamura K, Kikuchi M, Terasako K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Kimura S, Nakasone H, Okuda S, Yamazaki R, Kanda J, Kako S, Tanaka Y, Tanihara A, Nishida J, Kanda Y Kawamura K, Kikuchi M, Terasako K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Kimura S, Nakasone H, Okuda S, Yamazaki R, Kanda J, Kako S, Tanaka Y, Tanihara A, Nishida J, Kanda Y Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies. Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies. Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 49, 2, 334-340 Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 49, 2, 334-340 Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 49, 2, 334-340 2013/10 公開
Machishima T, Kako S, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kanda J, Yamazaki R, Nishida J, Kanda Y Machishima T, Kako S, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kanda J, Yamazaki R, Nishida J, Kanda Y Machishima T, Kako S, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kanda J, Yamazaki R, Nishida J, Kanda Y The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL. The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL. The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL. Clinical transplantation, 27, 5, 749-756 Clinical transplantation, 27, 5, 749-756 Clinical transplantation, 27, 5, 749-756 2013/09 公開
Kanda J Kanda J Kanda J Effect of HLA mismatch on acute graft-versus-host disease. Effect of HLA mismatch on acute graft-versus-host disease. Effect of HLA mismatch on acute graft-versus-host disease. International journal of hematology, 98, 3, 300-308 International journal of hematology, 98, 3, 300-308 International journal of hematology, 98, 3, 300-308 2013/09 公開
Sato M, Nakasone H, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Kawamura K, Ashizawa M, Machishima T, Terasako K, Kimura SI, Kikuchi M, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Kako S, Nishida J, Kanda Y Sato M, Nakasone H, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Kawamura K, Ashizawa M, Machishima T, Terasako K, Kimura SI, Kikuchi M, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Kako S, Nishida J, Kanda Y Sato M, Nakasone H, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Kawamura K, Ashizawa M, Machishima T, Terasako K, Kimura SI, Kikuchi M, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Kako S, Nishida J, Kanda Y Prediction of infectious events by the high-sensitivity C-reactive protein level before autologous hematopoietic cell transplantation for lymphoma and multiple myeloma. Prediction of infectious events by the high-sensitivity C-reactive protein level before autologous hematopoietic cell transplantation for lymphoma and multiple myeloma. Prediction of infectious events by the high-sensitivity C-reactive protein level before autologous hematopoietic cell transplantation for lymphoma and multiple myeloma. Transplant infectious disease : an official journal of the Transplantation Society, 15, 4, 169-171 Transplant infectious disease : an official journal of the Transplantation Society, 15, 4, 169-171 Transplant infectious disease : an official journal of the Transplantation Society, 15, 4, 169-171 2013/08 公開
Murata M, Nakasone H, Kanda J, Nakane T, Furukawa T, Fukuda T, Mori T, Taniguchi S, Eto T, Ohashi K, Hino M, Inoue M, Ogawa H, Atsuta Y, Nagamura-Inoue T, Yabe H, Morishima Y, Sakamaki H, Suzuki R Murata M, Nakasone H, Kanda J, Nakane T, Furukawa T, Fukuda T, Mori T, Taniguchi S, Eto T, Ohashi K, Hino M, Inoue M, Ogawa H, Atsuta Y, Nagamura-Inoue T, Yabe H, Morishima Y, Sakamaki H, Suzuki R Murata M, Nakasone H, Kanda J, Nakane T, Furukawa T, Fukuda T, Mori T, Taniguchi S, Eto T, Ohashi K, Hino M, Inoue M, Ogawa H, Atsuta Y, Nagamura-Inoue T, Yabe H, Morishima Y, Sakamaki H, Suzuki R Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation. Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation. Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19, 8, 1183-1189 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19, 8, 1183-1189 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19, 8, 1183-1189 2013/08 公開
Yamazaki R, Nakasone H, Tanaka Y, Sato M, Terasako K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Yamazaki R, Nakasone H, Tanaka Y, Sato M, Terasako K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Yamazaki R, Nakasone H, Tanaka Y, Sato M, Terasako K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation. Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation. Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19, 7, 1013-1020 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19, 7, 1013-1020 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19, 7, 1013-1020 2013/07 公開
Kanda J, Kaynar L, Kanda Y, Prasad VK, Parikh SH, Lan L, Shen T, Rizzieri DA, Long GD, Sullivan KM, Gasparetto C, Chute JP, Morris A, Winkel S, McPherson J, Kurtzberg J, Chao NJ, Horwitz ME Kanda J, Kaynar L, Kanda Y, Prasad VK, Parikh SH, Lan L, Shen T, Rizzieri DA, Long GD, Sullivan KM, Gasparetto C, Chute JP, Morris A, Winkel S, McPherson J, Kurtzberg J, Chao NJ, Horwitz ME Kanda J, Kaynar L, Kanda Y, Prasad VK, Parikh SH, Lan L, Shen T, Rizzieri DA, Long GD, Sullivan KM, Gasparetto C, Chute JP, Morris A, Winkel S, McPherson J, Kurtzberg J, Chao NJ, Horwitz ME Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. Bone marrow transplantation, 48, 7, 926-931 Bone marrow transplantation, 48, 7, 926-931 Bone marrow transplantation, 48, 7, 926-931 2013/07 公開
Nakasone H, Kanda J, Yano S, Atsuta Y, Ago H, Fukuda T, Kakihana K, Adachi T, Yujiri T, Taniguchi S, Taguchi J, Morishima Y, Nagamura T, Sakamaki H, Mori T, Murata M, GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation Nakasone H, Kanda J, Yano S, Atsuta Y, Ago H, Fukuda T, Kakihana K, Adachi T, Yujiri T, Taniguchi S, Taguchi J, Morishima Y, Nagamura T, Sakamaki H, Mori T, Murata M, GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation Nakasone H, Kanda J, Yano S, Atsuta Y, Ago H, Fukuda T, Kakihana K, Adachi T, Yujiri T, Taniguchi S, Taguchi J, Morishima Y, Nagamura T, Sakamaki H, Mori T, Murata M, GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation. Transplant international : official journal of the European Society for Organ Transplantation, 26, 6, 631-639 Transplant international : official journal of the European Society for Organ Transplantation, 26, 6, 631-639 Transplant international : official journal of the European Society for Organ Transplantation, 26, 6, 631-639 2013/06 公開
Kanda Y, Kanda J, Atsuta Y, Maeda Y, Ichinohe T, Ohashi K, Fukuda T, Miyamura K, Iida H, Mori T, Iwato K, Eto T, Kawa K, Morita S, Morishima Y Kanda Y, Kanda J, Atsuta Y, Maeda Y, Ichinohe T, Ohashi K, Fukuda T, Miyamura K, Iida H, Mori T, Iwato K, Eto T, Kawa K, Morita S, Morishima Y Kanda Y, Kanda J, Atsuta Y, Maeda Y, Ichinohe T, Ohashi K, Fukuda T, Miyamura K, Iida H, Mori T, Iwato K, Eto T, Kawa K, Morita S, Morishima Y Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow British journal of haematology, 161, 4, 566-577 British journal of haematology, 161, 4, 566-577 British journal of haematology, 161, 4, 566-577 2013/05 公開
Atsuta Y, Kanda J, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H, Ohashi K, Ohno Y, Onishi Y, Aotsuka N, Nagamura-Inoue T, Kato K, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Atsuta Y, Kanda J, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H, Ohashi K, Ohno Y, Onishi Y, Aotsuka N, Nagamura-Inoue T, Kato K, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Atsuta Y, Kanda J, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H, Ohashi K, Ohno Y, Onishi Y, Aotsuka N, Nagamura-Inoue T, Kato K, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia. Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia. Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia. Haematologica, 98, 5, 814-822 Haematologica, 98, 5, 814-822 Haematologica, 98, 5, 814-822 2013/05 公開
Sato M, Nakasone H, Oshima K, Ishihara Y, Wada H, Sakamoto K, Kawamura K, Ashizawa M, Machishima T, Terasako K, Kimura S, Kikuchi M, Okuda S, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Kako S, Nishida J, Kanda Y Sato M, Nakasone H, Oshima K, Ishihara Y, Wada H, Sakamoto K, Kawamura K, Ashizawa M, Machishima T, Terasako K, Kimura S, Kikuchi M, Okuda S, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Kako S, Nishida J, Kanda Y Sato M, Nakasone H, Oshima K, Ishihara Y, Wada H, Sakamoto K, Kawamura K, Ashizawa M, Machishima T, Terasako K, Kimura S, Kikuchi M, Okuda S, Tanihara A, Yamazaki R, Tanaka Y, Kanda J, Kako S, Nishida J, Kanda Y Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT. Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT. Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT. Bone marrow transplantation, 48, 5, 698-702 Bone marrow transplantation, 48, 5, 698-702 Bone marrow transplantation, 48, 5, 698-702 2013/05 公開
Kanda J, Atsuta Y, Wake A, Ichinohe T, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H, Ohashi K, Ohno Y, Aotsuka N, Onishi Y, Kato K, Nagamura-Inoue T, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Kanda J, Atsuta Y, Wake A, Ichinohe T, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H, Ohashi K, Ohno Y, Aotsuka N, Onishi Y, Kato K, Nagamura-Inoue T, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Kanda J, Atsuta Y, Wake A, Ichinohe T, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H, Ohashi K, Ohno Y, Aotsuka N, Onishi Y, Kato K, Nagamura-Inoue T, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord blood transplantation. Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord blood transplantation. Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord blood transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19, 2, 247-254 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19, 2, 247-254 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19, 2, 247-254 2013/02 公開
Kanda J, Ichinohe T, Kato S, Uchida N, Terakura S, Fukuda T, Hidaka M, Ueda Y, Kondo T, Taniguchi S, Takahashi S, Nagamura-Inoue T, Tanaka J, Atsuta Y, Miyamura K, Kanda Y, Donor/Source Working Group and HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Kanda J, Ichinohe T, Kato S, Uchida N, Terakura S, Fukuda T, Hidaka M, Ueda Y, Kondo T, Taniguchi S, Takahashi S, Nagamura-Inoue T, Tanaka J, Atsuta Y, Miyamura K, Kanda Y, Donor/Source Working Group and HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Kanda J, Ichinohe T, Kato S, Uchida N, Terakura S, Fukuda T, Hidaka M, Ueda Y, Kondo T, Taniguchi S, Takahashi S, Nagamura-Inoue T, Tanaka J, Atsuta Y, Miyamura K, Kanda Y, Donor/Source Working Group and HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction. Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction. Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction. Leukemia, 27, 2, 286-294 Leukemia, 27, 2, 286-294 Leukemia, 27, 2, 286-294 2013/02 公開
Sakamoto S, Kawabata H, Kanda J, Uchiyama T, Mizumoto C, Kondo T, Yamashita K, Ichinohe T, Ishikawa T, Kadowaki N, Takaori-Kondo A Sakamoto S, Kawabata H, Kanda J, Uchiyama T, Mizumoto C, Kondo T, Yamashita K, Ichinohe T, Ishikawa T, Kadowaki N, Takaori-Kondo A Sakamoto S, Kawabata H, Kanda J, Uchiyama T, Mizumoto C, Kondo T, Yamashita K, Ichinohe T, Ishikawa T, Kadowaki N, Takaori-Kondo A Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. International journal of hematology, 97, 1, 109-116 International journal of hematology, 97, 1, 109-116 International journal of hematology, 97, 1, 109-116 2013/01 公開
Ashizawa M, Oshima K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Machishima T, Kimura S, Kikuchi M, Nakasone H, Okuda S, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Ashizawa M, Oshima K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Machishima T, Kimura S, Kikuchi M, Nakasone H, Okuda S, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Ashizawa M, Oshima K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Machishima T, Kimura S, Kikuchi M, Nakasone H, Okuda S, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Hyperbilirubinemia in the early phase after allogeneic HSCT: prognostic significance of the alkaline phosphatase/total bilirubin ratio. Hyperbilirubinemia in the early phase after allogeneic HSCT: prognostic significance of the alkaline phosphatase/total bilirubin ratio. Hyperbilirubinemia in the early phase after allogeneic HSCT: prognostic significance of the alkaline phosphatase/total bilirubin ratio. Bone marrow transplantation, 48, 1, 94-98 Bone marrow transplantation, 48, 1, 94-98 Bone marrow transplantation, 48, 1, 94-98 2013/01 公開
Sakamoto K, Nakasone H, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Ashizawa M, Sato M, Terasako-Saito K, Machishima T, Kimura S, Kikuchi M, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Sakamoto K, Nakasone H, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Ashizawa M, Sato M, Terasako-Saito K, Machishima T, Kimura S, Kikuchi M, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Sakamoto K, Nakasone H, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Ashizawa M, Sato M, Terasako-Saito K, Machishima T, Kimura S, Kikuchi M, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides. Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides. Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides. PloS one, 8, 9, e73754 PloS one, 8, 9, e73754 PloS one, 8, 9, e73754 2013 公開
Mizumoto C, Kawabata H, Uchiyama T, Sakamoto S, Kanda J, Tomosugi N, Takaori-Kondo A Mizumoto C, Kawabata H, Uchiyama T, Sakamoto S, Kanda J, Tomosugi N, Takaori-Kondo A Mizumoto C, Kawabata H, Uchiyama T, Sakamoto S, Kanda J, Tomosugi N, Takaori-Kondo A Acidic milieu augments the expression of hepcidin, the central regulator of iron homeostasis. Acidic milieu augments the expression of hepcidin, the central regulator of iron homeostasis. Acidic milieu augments the expression of hepcidin, the central regulator of iron homeostasis. International journal of hematology, 96, 6, 701-709 International journal of hematology, 96, 6, 701-709 International journal of hematology, 96, 6, 701-709 2012/12 公開
Tanaka Y, Nakasone H, Yamazaki R, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Sato M, Terasako K, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Tanaka Y, Nakasone H, Yamazaki R, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Sato M, Terasako K, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Tanaka Y, Nakasone H, Yamazaki R, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Sato M, Terasako K, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation. Journal of clinical immunology, 32, 6, 1340-1352 Journal of clinical immunology, 32, 6, 1340-1352 Journal of clinical immunology, 32, 6, 1340-1352 2012/12 公開
Kanda J, Chiou LW, Szabolcs P, Sempowski GD, Rizzieri DA, Long GD, Sullivan KM, Gasparetto C, Chute JP, Morris A, McPherson J, Hale J, Livingston JA, Broadwater G, Niedzwiecki D, Chao NJ, Horwitz ME Kanda J, Chiou LW, Szabolcs P, Sempowski GD, Rizzieri DA, Long GD, Sullivan KM, Gasparetto C, Chute JP, Morris A, McPherson J, Hale J, Livingston JA, Broadwater G, Niedzwiecki D, Chao NJ, Horwitz ME Kanda J, Chiou LW, Szabolcs P, Sempowski GD, Rizzieri DA, Long GD, Sullivan KM, Gasparetto C, Chute JP, Morris A, McPherson J, Hale J, Livingston JA, Broadwater G, Niedzwiecki D, Chao NJ, Horwitz ME Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 18, 11, 1664-1676 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 18, 11, 1664-1676 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 18, 11, 1664-1676 2012/11 公開
Kanda J, Horwitz ME, Long GD, Gasparetto C, Sullivan KM, Chute JP, Morris A, Hennig T, Li Z, Chao NJ, Rizzieri DA Kanda J, Horwitz ME, Long GD, Gasparetto C, Sullivan KM, Chute JP, Morris A, Hennig T, Li Z, Chao NJ, Rizzieri DA Kanda J, Horwitz ME, Long GD, Gasparetto C, Sullivan KM, Chute JP, Morris A, Hennig T, Li Z, Chao NJ, Rizzieri DA Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation. Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation. Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation. Bone marrow transplantation, 47, 5, 700-705 Bone marrow transplantation, 47, 5, 700-705 Bone marrow transplantation, 47, 5, 700-705 2012/05 公開
Chihara D, Matsuo K, Kanda J, Hosono S, Ito H, Nakamura S, Seto M, Morishima Y, Tajima K, Tanaka H Chihara D, Matsuo K, Kanda J, Hosono S, Ito H, Nakamura S, Seto M, Morishima Y, Tajima K, Tanaka H Chihara D, Matsuo K, Kanda J, Hosono S, Ito H, Nakamura S, Seto M, Morishima Y, Tajima K, Tanaka H Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case-control study in Japan. Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case-control study in Japan. Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case-control study in Japan. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 23, 4, 1061-1066 Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 23, 4, 1061-1066 Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 23, 4, 1061-1066 2012/04 公開
Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood, 119, 9, 2141-2148 Blood, 119, 9, 2141-2148 Blood, 119, 9, 2141-2148 2012/03 公開
Kanda J, Saji H, Fukuda T, Kobayashi T, Miyamura K, Eto T, Kurokawa M, Kanamori H, Mori T, Hidaka M, Iwato K, Yoshida T, Sakamaki H, Tanaka J, Kawa K, Morishima Y, Suzuki R, Atsuta Y, Kanda Y Kanda J, Saji H, Fukuda T, Kobayashi T, Miyamura K, Eto T, Kurokawa M, Kanamori H, Mori T, Hidaka M, Iwato K, Yoshida T, Sakamaki H, Tanaka J, Kawa K, Morishima Y, Suzuki R, Atsuta Y, Kanda Y Kanda J, Saji H, Fukuda T, Kobayashi T, Miyamura K, Eto T, Kurokawa M, Kanamori H, Mori T, Hidaka M, Iwato K, Yoshida T, Sakamaki H, Tanaka J, Kawa K, Morishima Y, Suzuki R, Atsuta Y, Kanda Y Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study. Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study. Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study. Blood, 119, 10, 2409-2416 Blood, 119, 10, 2409-2416 Blood, 119, 10, 2409-2416 2012/03 公開
Kanda J, Rizzieri DA, Gasparetto C, Long GD, Chute JP, Sullivan KM, Morris A, Smith CA, Hogge DE, Nitta J, Song K, Niedzwiecki D, Chao NJ, Horwitz ME Kanda J, Rizzieri DA, Gasparetto C, Long GD, Chute JP, Sullivan KM, Morris A, Smith CA, Hogge DE, Nitta J, Song K, Niedzwiecki D, Chao NJ, Horwitz ME Kanda J, Rizzieri DA, Gasparetto C, Long GD, Chute JP, Sullivan KM, Morris A, Smith CA, Hogge DE, Nitta J, Song K, Niedzwiecki D, Chao NJ, Horwitz ME Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning. Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning. Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 17, 6, 867-874 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 17, 6, 867-874 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 17, 6, 867-874 2011/06 公開
Kanda J, Lopez RD, Rizzieri DA Kanda J, Lopez RD, Rizzieri DA Kanda J, Lopez RD, Rizzieri DA Alemtuzumab for the prevention and treatment of graft-versus-host disease. Alemtuzumab for the prevention and treatment of graft-versus-host disease. Alemtuzumab for the prevention and treatment of graft-versus-host disease. International journal of hematology, 93, 5, 586-593 International journal of hematology, 93, 5, 586-593 International journal of hematology, 93, 5, 586-593 2011/05 公開
Sato T, Ichinohe T, Kanda J, Yamashita K, Kondo T, Ishikawa T, Uchiyama T, Takaori-Kondo A Sato T, Ichinohe T, Kanda J, Yamashita K, Kondo T, Ishikawa T, Uchiyama T, Takaori-Kondo A Sato T, Ichinohe T, Kanda J, Yamashita K, Kondo T, Ishikawa T, Uchiyama T, Takaori-Kondo A Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria. International journal of hematology, 93, 4, 532-541 International journal of hematology, 93, 4, 532-541 International journal of hematology, 93, 4, 532-541 2011/04 公開
Kanda J, Mizumoto C, Ichinohe T, Kawabata H, Saito T, Yamashita K, Kondo T, Takakura S, Ichiyama S, Uchiyama T, Ishikawa T Kanda J, Mizumoto C, Ichinohe T, Kawabata H, Saito T, Yamashita K, Kondo T, Takakura S, Ichiyama S, Uchiyama T, Ishikawa T Kanda J, Mizumoto C, Ichinohe T, Kawabata H, Saito T, Yamashita K, Kondo T, Takakura S, Ichiyama S, Uchiyama T, Ishikawa T Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation. Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation. Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation. Bone marrow transplantation, 46, 2, 208-216 Bone marrow transplantation, 46, 2, 208-216 Bone marrow transplantation, 46, 2, 208-216 2011/02 公開
Kanda J, Kawabata H, Chao NJ Kanda J, Kawabata H, Chao NJ Kanda J, Kawabata H, Chao NJ Iron overload and allogeneic hematopoietic stem-cell transplantation. Iron overload and allogeneic hematopoietic stem-cell transplantation. Iron overload and allogeneic hematopoietic stem-cell transplantation. Expert review of hematology, 4, 1, 71-80 Expert review of hematology, 4, 1, 71-80 Expert review of hematology, 4, 1, 71-80 2011/02 公開
Kanda J, Chao NJ, Rizzieri DA Kanda J, Chao NJ, Rizzieri DA Kanda J, Chao NJ, Rizzieri DA Haploidentical transplantation for leukemia. Haploidentical transplantation for leukemia. Haploidentical transplantation for leukemia. Current oncology reports, 12, 5, 292-301 Current oncology reports, 12, 5, 292-301 Current oncology reports, 12, 5, 292-301 2010/09 公開
Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood, 116, 8, 1369-1376 Blood, 116, 8, 1369-1376 Blood, 116, 8, 1369-1376 2010/08 公開
Kanda J, Ichinohe T, Saito T, Yamashita K, Kondo T, Ishikawa T, Ichiyama S, Uchiyama T Kanda J, Ichinohe T, Saito T, Yamashita K, Kondo T, Ishikawa T, Ichiyama S, Uchiyama T Kanda J, Ichinohe T, Saito T, Yamashita K, Kondo T, Ishikawa T, Ichiyama S, Uchiyama T Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning. Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning. Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning. Bone marrow transplantation, 45, 8, 1369-1371 Bone marrow transplantation, 45, 8, 1369-1371 Bone marrow transplantation, 45, 8, 1369-1371 2010/08 公開
Kanda J, Matsuo K, Inoue M, Iwasaki M, Sawada N, Shimazu T, Yamaji T, Sasazuki S, Tsugane S, Japan Public Health Center-based Prospective Study Group Kanda J, Matsuo K, Inoue M, Iwasaki M, Sawada N, Shimazu T, Yamaji T, Sasazuki S, Tsugane S, Japan Public Health Center-based Prospective Study Group Kanda J, Matsuo K, Inoue M, Iwasaki M, Sawada N, Shimazu T, Yamaji T, Sasazuki S, Tsugane S, Japan Public Health Center-based Prospective Study Group Association of anthropometric characteristics with the risk of malignant lymphoma and plasma cell myeloma in a Japanese population: a population-based cohort study. Association of anthropometric characteristics with the risk of malignant lymphoma and plasma cell myeloma in a Japanese population: a population-based cohort study. Association of anthropometric characteristics with the risk of malignant lymphoma and plasma cell myeloma in a Japanese population: a population-based cohort study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19, 6, 1623-1631 Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19, 6, 1623-1631 Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19, 6, 1623-1631 2010/06 公開
Kanda J, Matsuo K, Suzuki T, Hosono S, Ito H, Ichinohe T, Seto M, Morishima Y, Tajima K, Tanaka H Kanda J, Matsuo K, Suzuki T, Hosono S, Ito H, Ichinohe T, Seto M, Morishima Y, Tajima K, Tanaka H Kanda J, Matsuo K, Suzuki T, Hosono S, Ito H, Ichinohe T, Seto M, Morishima Y, Tajima K, Tanaka H Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. International journal of cancer, 126, 10, 2416-2425 International journal of cancer, 126, 10, 2416-2425 International journal of cancer, 126, 10, 2416-2425 2010/05 公開
Kanda J, Matsuo K, Inoue M, Iwasaki M, Sawada N, Shimazu T, Yamaji T, Sasazuki S, Tsugane S, Japan Public Health Center-based Prospective Study Group Kanda J, Matsuo K, Inoue M, Iwasaki M, Sawada N, Shimazu T, Yamaji T, Sasazuki S, Tsugane S, Japan Public Health Center-based Prospective Study Group Kanda J, Matsuo K, Inoue M, Iwasaki M, Sawada N, Shimazu T, Yamaji T, Sasazuki S, Tsugane S, Japan Public Health Center-based Prospective Study Group Association of alcohol intake with the risk of malignant lymphoma and plasma cell myeloma in Japanese: a population-based cohort study (Japan Public Health Center-based Prospective Study). Association of alcohol intake with the risk of malignant lymphoma and plasma cell myeloma in Japanese: a population-based cohort study (Japan Public Health Center-based Prospective Study). Association of alcohol intake with the risk of malignant lymphoma and plasma cell myeloma in Japanese: a population-based cohort study (Japan Public Health Center-based Prospective Study). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19, 2, 429-434 Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19, 2, 429-434 Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19, 2, 429-434 2010/02 公開
Kunitomi A, Iida H, Kamiya Y, Hayashi M, Suwa T, Kanda J, Sao H Kunitomi A, Iida H, Kamiya Y, Hayashi M, Suwa T, Kanda J, Sao H Kunitomi A, Iida H, Kamiya Y, Hayashi M, Suwa T, Kanda J, Sao H Insomnia and depression during protective isolation in patients with hematological disorders. Insomnia and depression during protective isolation in patients with hematological disorders. Insomnia and depression during protective isolation in patients with hematological disorders. Internal medicine (Tokyo, Japan), 49, 1, 17-22 Internal medicine (Tokyo, Japan), 49, 1, 17-22 Internal medicine (Tokyo, Japan), 49, 1, 17-22 2010 公開
Kanda J, Uchiyama T, Tomosugi N, Higuchi M, Uchiyama T, Kawabata H Kanda J, Uchiyama T, Tomosugi N, Higuchi M, Uchiyama T, Kawabata H Kanda J, Uchiyama T, Tomosugi N, Higuchi M, Uchiyama T, Kawabata H Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines. Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines. Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines. International journal of hematology, 90, 5, 545-552 International journal of hematology, 90, 5, 545-552 International journal of hematology, 90, 5, 545-552 2009/12 公開
Kanda J, Matsuo K, Kawase T, Suzuki T, Ichinohe T, Seto M, Morishima Y, Tajima K, Tanaka H Kanda J, Matsuo K, Kawase T, Suzuki T, Ichinohe T, Seto M, Morishima Y, Tajima K, Tanaka H Kanda J, Matsuo K, Kawase T, Suzuki T, Ichinohe T, Seto M, Morishima Y, Tajima K, Tanaka H Association of alcohol intake and smoking with malignant lymphoma risk in Japanese: a hospital-based case-control study at Aichi Cancer Center. Association of alcohol intake and smoking with malignant lymphoma risk in Japanese: a hospital-based case-control study at Aichi Cancer Center. Association of alcohol intake and smoking with malignant lymphoma risk in Japanese: a hospital-based case-control study at Aichi Cancer Center. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 18, 9, 2436-2441 Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 18, 9, 2436-2441 Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 18, 9, 2436-2441 2009/09 公開
Kanda J, Ichinohe T, Shimazaki C, Hamaguchi M, Watanabe A, Ishida H, Yoshihara T, Morimoto A, Uoshima N, Adachi S, Inukai T, Sawada A, Oka K, Itoh M, Hino M, Maruya E, Saji H, Uchiyama T, Kodera Y Kanda J, Ichinohe T, Shimazaki C, Hamaguchi M, Watanabe A, Ishida H, Yoshihara T, Morimoto A, Uoshima N, Adachi S, Inukai T, Sawada A, Oka K, Itoh M, Hino M, Maruya E, Saji H, Uchiyama T, Kodera Y Kanda J, Ichinohe T, Shimazaki C, Hamaguchi M, Watanabe A, Ishida H, Yoshihara T, Morimoto A, Uoshima N, Adachi S, Inukai T, Sawada A, Oka K, Itoh M, Hino M, Maruya E, Saji H, Uchiyama T, Kodera Y Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD. Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD. Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD. Bone marrow transplantation, 44, 5, 327-329 Bone marrow transplantation, 44, 5, 327-329 Bone marrow transplantation, 44, 5, 327-329 2009/09 公開
Kanda J, Mizumoto C, Kawabata H, Ichinohe T, Tsuchida H, Tomosugi N, Matsuo K, Yamashita K, Kondo T, Ishikawa T, Uchiyama T Kanda J, Mizumoto C, Kawabata H, Ichinohe T, Tsuchida H, Tomosugi N, Matsuo K, Yamashita K, Kondo T, Ishikawa T, Uchiyama T Kanda J, Mizumoto C, Kawabata H, Ichinohe T, Tsuchida H, Tomosugi N, Matsuo K, Yamashita K, Kondo T, Ishikawa T, Uchiyama T Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation. Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation. Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 15, 8, 956-962 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 15, 8, 956-962 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 15, 8, 956-962 2009/08 公開
Mizumoto C, Kanda J, Ichinohe T, Ishikawa T, Matsui M, Kadowaki N, Kondo T, Imada K, Hishizawa M, Kawabata H, Nishikori M, Yamashita K, Takaori-Kondo A, Hori T, Uchiyama T Mizumoto C, Kanda J, Ichinohe T, Ishikawa T, Matsui M, Kadowaki N, Kondo T, Imada K, Hishizawa M, Kawabata H, Nishikori M, Yamashita K, Takaori-Kondo A, Hori T, Uchiyama T Mizumoto C, Kanda J, Ichinohe T, Ishikawa T, Matsui M, Kadowaki N, Kondo T, Imada K, Hishizawa M, Kawabata H, Nishikori M, Yamashita K, Takaori-Kondo A, Hori T, Uchiyama T Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning. Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning. Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning. International journal of hematology, 89, 4, 538-545 International journal of hematology, 89, 4, 538-545 International journal of hematology, 89, 4, 538-545 2009/05 公開
Kanda J, Ichinohe T, Matsuo K, Benjamin RJ, Klumpp TR, Rozman P, Blumberg N, Mehta J, Sohn SK, Uchiyama T Kanda J, Ichinohe T, Matsuo K, Benjamin RJ, Klumpp TR, Rozman P, Blumberg N, Mehta J, Sohn SK, Uchiyama T Kanda J, Ichinohe T, Matsuo K, Benjamin RJ, Klumpp TR, Rozman P, Blumberg N, Mehta J, Sohn SK, Uchiyama T Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies. Transfusion, 49, 4, 624-635 Transfusion, 49, 4, 624-635 Transfusion, 49, 4, 624-635 2009/04 公開
Kanda J, Matsuo K, Suzuki T, Kawase T, Hiraki A, Watanabe M, Mizuno N, Sawaki A, Yamao K, Tajima K, Tanaka H Kanda J, Matsuo K, Suzuki T, Kawase T, Hiraki A, Watanabe M, Mizuno N, Sawaki A, Yamao K, Tajima K, Tanaka H Kanda J, Matsuo K, Suzuki T, Kawase T, Hiraki A, Watanabe M, Mizuno N, Sawaki A, Yamao K, Tajima K, Tanaka H Impact of alcohol consumption with polymorphisms in alcohol-metabolizing enzymes on pancreatic cancer risk in Japanese. Impact of alcohol consumption with polymorphisms in alcohol-metabolizing enzymes on pancreatic cancer risk in Japanese. Impact of alcohol consumption with polymorphisms in alcohol-metabolizing enzymes on pancreatic cancer risk in Japanese. Cancer science, 100, 2, 296-302 Cancer science, 100, 2, 296-302 Cancer science, 100, 2, 296-302 2009/02 公開
Kanda J, Mizumoto C, Kawabata H, Tsuchida H, Tomosugi N, Matsuo K, Uchiyama T Kanda J, Mizumoto C, Kawabata H, Tsuchida H, Tomosugi N, Matsuo K, Uchiyama T Kanda J, Mizumoto C, Kawabata H, Tsuchida H, Tomosugi N, Matsuo K, Uchiyama T Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Haematologica, 93, 10, 1550-1554 Haematologica, 93, 10, 1550-1554 Haematologica, 93, 10, 1550-1554 2008/10 公開
Tanaka Y, Kondo T, Kishimoto W, Kanda J, Tashima M, Mizumoto C, Ichinohe T, Ishikawa T, Uchiyama T, Haga H, Manabe T Tanaka Y, Kondo T, Kishimoto W, Kanda J, Tashima M, Mizumoto C, Ichinohe T, Ishikawa T, Uchiyama T, Haga H, Manabe T Tanaka Y, Kondo T, Kishimoto W, Kanda J, Tashima M, Mizumoto C, Ichinohe T, Ishikawa T, Uchiyama T, Haga H, Manabe T [Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia]. [Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia]. [Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 49, 4, 263-269 [Rinsho ketsueki] The Japanese journal of clinical hematology, 49, 4, 263-269 [Rinsho ketsueki] The Japanese journal of clinical hematology, 49, 4, 263-269 2008/04 公開
Yamamoto R, Takaori-Kondo A, Kanda J, Imada K, Ichinohe T, Ishikawa T, Ohmori K, Uchiyama T Yamamoto R, Takaori-Kondo A, Kanda J, Imada K, Ichinohe T, Ishikawa T, Ohmori K, Uchiyama T Yamamoto R, Takaori-Kondo A, Kanda J, Imada K, Ichinohe T, Ishikawa T, Ohmori K, Uchiyama T Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation. Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation. Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation. Bone marrow transplantation, 41, 6, 591-593 Bone marrow transplantation, 41, 6, 591-593 Bone marrow transplantation, 41, 6, 591-593 2008/03 公開
Kawabata H, Tomosugi N, Kanda J, Tanaka Y, Yoshizaki K, Uchiyama T Kawabata H, Tomosugi N, Kanda J, Tanaka Y, Yoshizaki K, Uchiyama T Kawabata H, Tomosugi N, Kanda J, Tanaka Y, Yoshizaki K, Uchiyama T Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease. Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease. Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease. Haematologica, 92, 6, 857-858 Haematologica, 92, 6, 857-858 Haematologica, 92, 6, 857-858 2007/06 公開
Kanda J, Kawabata H, Yamaji Y, Ichinohe T, Ishikawa T, Tamura T, Furukawa Y, Kimura T, Kita T, Uchiyama T Kanda J, Kawabata H, Yamaji Y, Ichinohe T, Ishikawa T, Tamura T, Furukawa Y, Kimura T, Kita T, Uchiyama T Kanda J, Kawabata H, Yamaji Y, Ichinohe T, Ishikawa T, Tamura T, Furukawa Y, Kimura T, Kita T, Uchiyama T Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody. Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody. Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody. International journal of hematology, 85, 3, 207-211 International journal of hematology, 85, 3, 207-211 International journal of hematology, 85, 3, 207-211 2007/04 公開
Kanda J, Chonabayashi K, Watanabe M, Arima N, Tsudo M Kanda J, Chonabayashi K, Watanabe M, Arima N, Tsudo M Kanda J, Chonabayashi K, Watanabe M, Arima N, Tsudo M [Successful treatment with cyclosporine of sodium valproate-induced pure red cell aplasia]. [Successful treatment with cyclosporine of sodium valproate-induced pure red cell aplasia]. [Successful treatment with cyclosporine of sodium valproate-induced pure red cell aplasia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 46, 10, 1114-1117 [Rinsho ketsueki] The Japanese journal of clinical hematology, 46, 10, 1114-1117 [Rinsho ketsueki] The Japanese journal of clinical hematology, 46, 10, 1114-1117 2005/10 公開

  • <<
  • >>
  • 表示
タイトル言語:
学術賞等
賞の名称(日本語) 賞の名称(英語) 授与組織名(日本語) 授与組織名(英語) 年月
奨励賞 Encouragement Prize 日本造血細胞移植学会 The Japan Society for Hematopoietic Stem Cell Transplantation 2013/03/09
奨励賞 Encouragement Prize 日本血液学会 The Japanese Society of Hematology 2013/10/11
外部資金:競争的資金・科学研究費補助金
種別 代表/分担 テーマ(日本語) テーマ(英語) 期間
基盤研究(C) 代表 臨床データ解析による臍帯血移植成績向上のための国際標準アルゴリズム確立 (平成30年度分) 2018/04/01〜2019/03/31